Pages that link to "Q38090457"
Jump to navigation
Jump to search
The following pages link to Long-acting injectable antipsychotics and the development of postinjection delirium/sedation syndrome (PDSS). (Q38090457):
Displaying 8 items.
- The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal. (Q34418847) (← links)
- Safety of antipsychotic drugs: focus on therapeutic and adverse effects (Q38224339) (← links)
- Post-injection delirium/sedation syndrome in patients treated with olanzapine pamoate: mechanism, incidence, and management (Q38271353) (← links)
- Olanzapine pamoate for the treatment of schizophrenia--a safety evaluation (Q38694855) (← links)
- "Long-acting" olanzapine in maintenance therapy of schizophrenia: A study with plasma levels (Q41641237) (← links)
- Severe acute dystonia/akathisia after paliperidone palmitate application--a case study (Q43433877) (← links)
- Long-acting formulation leading to severe long-term adverse effects: a case report of fluphenazine and persistent extrapyramidal symptoms. (Q47830145) (← links)
- Oral liquid antipsychotic formulation in the treatment of psychosis (Q58201754) (← links)